
Sign up to save your podcasts
Or


Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.
TPM E48 highlights >
Episode 48 links:
By Genialis4.7
77 ratings
Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.
TPM E48 highlights >
Episode 48 links:

21,996 Listeners

229,106 Listeners

4,356 Listeners

112,758 Listeners

56,512 Listeners

10,271 Listeners

9,897 Listeners

5,475 Listeners

16,042 Listeners